TABLE 1.
Primer or probea | Sequenceb (5′-3′) | Nucleotide position |
---|---|---|
E7 forward primer | CGGACAGAGCCCATTACAATATT | 701-723 |
E7 reverse primer | CGCACAACCGAAGCGTAGA | 766-748 |
E7-specific probe | FAM-TAACCTTTTGTTGCAAGTGT-MGBNFQ | 725-744 |
E7 degenerate probe | FAM-TAACCTTYTGTTGCAAGTGT-MGBNFQ | 725-744 |
E2-specific forward primer | GCCGCGACCCATACCAAA | 3413-3430 |
E2 degenerate forward primer | GCCGCGACCCATWCCAAA | 3413-3430 |
Modified E2 degenerate forward primer 1 | CGCCGCGACCCATWCCAA | 3412-3429 |
Modified E2 degenerate forward primer 2 | CCGCCGCGACCCATWCCA | 3411-3428 |
Modified E2 degenerate forward primer 3 | YCCGCCGCGACCCATWCC | 3410-3427 |
E2 reverse primer | TCGCTGGATAGTCGTCTGTGTT | 3475-3454 |
E2-specific probe | TET-CGTCGCCTTGGGCACCGAA-TAMRA | 3433-3451 |
E2 degenerate probe | TET-CGTCGCCTTGGGCACCRAA-TAMRA | 3433-3451 |
Specific sets of primers and probes were as follows: for E2, E2-specific forward primer, E2 reverse primer, and E2-specific probe, and for E7, E7 forward and reverse primers and E7-specific probe. Degenerate sets of primers and probes were as follows: for E2, E2 degenerate forward primer, E2 reverse primer, and E2 degenerate probe, and for E7, E7 forward and reverse primers and E7 degenerate probe. In modified degenerate sets, the E2 degenerate forward primer was replaced with a modified E2 degenerate forward primer.
W, A or T; R, A or G; and Y, T or C. FAM, 6-carboxyfluorescein; MGBNFQ, minor groove binding nonfluorescent quencher; TET, tetrachloro-6-carboxy-fluorescein; TAMRA, 6-carboxytetramethylrhodamine.